Product Information
TESTOSTERONE 1% (25 MG/2.5 G) PK is a generic product labeled by Strides Pharma Inc., priced at $1.2039 per GM under NDC 64380015102. Its NADAC has been published 217 times since Aug 10, 2022.
FDA first approved this application on May 23, 2007. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/2.5g
Manufacturer
Strides Pharma Inc.NDC
64380015102
Classification
Generic
Dosage Form
GEL
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONEApproval Type
Generic (ANDA)
FDA Application
ANDA076744FDA Approved
5/23/2007
TE Code
AB1
On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE 1% (25 MG/2.5 G) PK has been published 217 times since Aug 10, 2022, and over the history we have for it it has declined 44.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2039 per GM |
|---|---|
| All-time high | $2.1618 (Aug 10, 2022) |
| All-time low | $0.8358 (Jul 17, 2024) |
| 52-week high | $2.1430 |
| 52-week low | $1.1305 |
| Median price | $1.4745 |
| Average price | $1.5007 |
| Largest weekly change | +70.2% (Aug 21, 2024) |
| Weeks tracked | 217 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Testosterone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE 1% (25 MG/2.5 G) PK?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE 1% (25 MG/2.5 G) PK, manufactured by Strides Pharma Inc., is $1.2039 per GM (NDC 64380015102), effective Sep 30, 2026.
How has the price of TESTOSTERONE 1% (25 MG/2.5 G) PK changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE 1% (25 MG/2.5 G) PK has declined 44.3%. It has been tracked across 217 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE 1% (25 MG/2.5 G) PK?
Since Aug 10, 2022, the NADAC for TESTOSTERONE 1% (25 MG/2.5 G) PK has ranged from a low of $0.8358 (Jul 17, 2024) to a high of $2.1618 (Aug 10, 2022), with a median of $1.4745 per GM.
Are there cheaper alternatives to TESTOSTERONE 1% (25 MG/2.5 G) PK?
No other NADAC-published product currently shares the active ingredient and strength of TESTOSTERONE 1% (25 MG/2.5 G) PK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TESTOSTERONE 1% (25 MG/2.5 G) PK?
TESTOSTERONE 1% (25 MG/2.5 G) PK (NDC 64380015102) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.